Arsenal Capital Partners, a New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies, recently announced its acquisition of IGM Resins, a provider of intermediates to the global ultraviolet radiation-cure coatings, inks, and adhesives industries. Headquartered in the Netherlands, IGM Resins is a global specialty chemical company and leading supplier of photoinitiators and acrylates. 

“We are delighted with the opportunity to invest in a global company with the ability to provide complete solutions to the highly attractive UV-cure end markets,” said John Televantos, a partner at Arsenal who co-heads the firm’s Specialty Industrials practice. “The acquisition of IGM Resins further builds on Arsenal’s broad portfolio and established expertise in the Specialty Chemicals and Materials sectors.”